Yukiko Okazaki

Yukiko Okazaki

UNVERIFIED PROFILE

Are you Yukiko Okazaki?   Register this Author

Register author
Yukiko Okazaki

Yukiko Okazaki

Publications by authors named "Yukiko Okazaki"

Are you Yukiko Okazaki?   Register this Author

16Publications

306Reads

26Profile Views

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial.

Lancet Diabetes Endocrinol 2017 12 24;5(12):951-964. Epub 2017 Oct 24.

Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Translational Systems Biology and Medicine Initiative, The University of Tokyo, Tokyo, Japan. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22138587173032
Publisher Site
http://dx.doi.org/10.1016/S2213-8587(17)30327-3DOI Listing
December 2017

Design of and rationale for the Japan Diabetes Optimal Integrated Treatment study for 3 major risk factors of cardiovascular diseases (J-DOIT3): a multicenter, open-label, randomized, parallel-group trial.

BMJ Open Diabetes Res Care 2016 25;4(1):e000123. Epub 2016 Jan 25.

Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Translational Systems Biology and Medicine Initiative (TSBMI), The University of Tokyo, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjdrc-2015-000123DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731753PMC
February 2016

Case of concurrence of anti-laminin gamma-1 pemphigoid and scabies.

J Dermatol 2015 Oct 1;42(10):1024-6. Epub 2015 Jul 1.

Department of Dermatology, Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology, Fukuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1346-8138.13020DOI Listing
October 2015

Case of acrodermatitis continua of Hallopeau following psoriasis with atypical clinical presentation.

J Dermatol 2014 Nov;41(11):1006-8

Department of Dermatology, Mito Saiseikai General Hospital, Ibaraki, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1346-8138.12639DOI Listing
November 2014

[Japan Diabetes Outcome Intervention Trial 3].

Nihon Rinsho 2012 May;70 Suppl 3:290-4

Department of Metabolic Disease, Graduate School of Medicine, The University of Tokyo.

View Article

Download full-text PDF

Source
May 2012

Adiponectin enhances insulin sensitivity by increasing hepatic IRS-2 expression via a macrophage-derived IL-6-dependent pathway.

Cell Metab 2011 Apr;13(4):401-412

Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, University of Tokyo, Tokyo 113-8655, Japan; Translational Systems Biology and Medicine Initiative (TSBMI), University of Tokyo, Tokyo 113-8655, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S155041311100083
Publisher Site
http://dx.doi.org/10.1016/j.cmet.2011.02.010DOI Listing
April 2011

[Japan Diabetes Outcome Intervention Trial 3].

Nihon Rinsho 2010 Nov;68 Suppl 9:87-90

Department of Metabolic Diseases, Graduate School of Medicine, The University of Tokyo.

View Article

Download full-text PDF

Source
November 2010

Decreased insulin secretion and accumulation of triglyceride in beta cells overexpressing a dominant-negative form of AMP-activated protein kinase.

Endocr J 2010 19;57(2):141-52. Epub 2009 Nov 19.

Department of Metabolic Diseases, Graduate School of Medicine, the University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, Japan.

View Article

Download full-text PDF

Source
June 2010

[Japan Diabetes Outcome Intervention Trial 3 (Japan Diabetes Optimal Integrated Treatment Study for 3 major risk factors of cardiovascular diseases: J-DOIT3)].

Nihon Rinsho 2010 May;68(5):861-4

Department of Metabolic Diseases, Graduate School of Medicine, The University of Tokyo.

View Article

Download full-text PDF

Source
May 2010

Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway.

Biochem Biophys Res Commun 2009 Apr 28;382(1):51-6. Epub 2009 Feb 28.

Department of Metabolic Diseases, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2009.02.131DOI Listing
April 2009